Drag

BALAXI PHARMACEUTICALS LIMITED

Healthcare BALAXI

24.38INR
-0.02 ( -0.08%)

Last update at 2026-01-30 15:45:33

Day Range

23.7424.57
LowHigh

52 Week Range

25.86 81.13
LowHigh

Fundamentals

  • Previous Close 24.40
  • Market Cap 1518.21M
  • Volume27,025
  • P/E Ratio 10.50
  • EBITDA 467.31M
  • Revenue TTM 2412.94M
  • Revenue Per Share TTM 46.91
  • Gross Profit TTM 1126.15M
  • Diluted EPS TTM 2.62

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 286.70M 20.15M 569.22M 545.22M 443.29M
Net income 250.70M -23.87M 459.63M 476.58M 381.37M
Total Revenue 2888.45M 2412.94M 3364.33M 2793.88M 2313.33M
Gross Profit 1268.60M 1126.15M 1340.17M 837.92M 591.85M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 3103.42M 2583.43M 2396.69M 1764.71M 996.80M
Intangible assets 6.61M 7.78M 9.10M 8.25M 8.25M
Other current assets 925.69M 100.08M 51.98M 0.28M 0.53M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -228.91M 340.74M 210.23M 55.33M -23.24M
Operating Cash -377.82M 48.66M 60.75M 341.45M 0.03M
Free Cash Flow -589.01M 32.97M -89.05M 68.00M -25.53M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change Price Market Cap (M) P/E Ratio
BALAXI
BALAXI PHARMACEUTICALS LIMITED 		-0.02 -0.08% 24.38 1518.21 10.50
BIOCON
Biocon Limited 		-3.90 -1.05% 368.40 569444.73 94.72
ANTHEM
Anthem Biosciences Ltd 		-0.65 -0.11% 606.75 416096.85 91.92
ONESOURCE
ONESOURCE SPECIALTY PHARMA LTD 		41.20 3.50% 1218.80 203986.14 501.41
CONCORDBIO
Concord Biotech Limited 		19.10 1.64% 1183.20 140309.66 43.31

Profile

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in Africa, the Caribbean Islands, and Latin America. The company offers pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpastes. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. Balaxi Pharmaceuticals Limited was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

BALAXI PHARMACEUTICALS LIMITED

Maps Towers, Hyderabad, India, 500096

Key Executives

No executive information available.

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.